Related Experiment Video
Updated: Oct 1, 2025

Stimulation of Notch Signaling in Mouse Osteoclast Precursors
Published on: February 28, 2017
Effect of cadmium on Rho GTPases signal transduction during osteoclast differentiation
Shuangjiang He1,2,3, Kanglei Zhang1,2,3, Ying Cao1,2,3
1College of Veterinary Medicine, Yangzhou University, Yangzhou, Jiangsu, China.
Abstract:
Osteoclasts are the key target cells for cadmium (Cd)-induced bone metabolism diseases, while Rho GTPases play an important role in osteoclast differentiation and bone resorption. To identify new therapeutic targets of Cd-induced bone diseases; we evaluated signal transduction through Rho GTPases during osteoclast differentiation under the influence of Cd. In osteoclastic precursor cells, 10 nM Cd induced pseudopodia stretching, promoted cell migration, upregulated the levels of Cdc42, and RhoQ mRNAs and downstream Rho-associated coiled-coil kinase 1 (ROCK1) and ROCK2 proteins, and downregulated the actin-related protein 2/3 (ARP2/3) levels. Cd at 2 and 5 μM shortened the pseudopodia, inhibited cell migration, and decreased ROCK1, ROCK2, and ARP2/3 protein levels; Cd at 5 μM also reduced the mRNA expression levels of Rac1, Rac2, and RhoU mRNAs and decreased the level of phosphorylated (p)-cofilin. In osteoclasts, 10 nM Cd induced the formation of sealing zones, slightly upregulated Cdc42 mRNA levels and ROCK2 and ARP2/3 protein levels and significantly reduced p-cofilin levels. Cd at 2 μM and 5 μM Cd blocked the fusion of precursor cells; and 5 μM Cd downregulated the expression levels of RhoB, Rac1, Rac3, and RhoU mRNAs, and ROCK1, p-cofilin and ARP2/3 protein levels, significantly. In vivo, Cd (at 5 or 25 mg/L) increased the levels of key proteins RhoA, Rac1/2/3, Cdc42, and RhoU and their mRNAs in bone marrow cells. In summary, the results suggested that Cd affected the differentiation process of osteoclast and altered the expression of several Rho GTPases, which might be crucial targets of Cd during the differentiation of osteoclasts.
Insights
Cadmium exposure impacts osteoclast differentiation by altering Rho GTPase signaling. Understanding these changes may reveal new therapeutic targets for cadmium-induced bone diseases.
Area of Science:
- Biochemistry
- Cell Biology
- Toxicology
Background:
- Osteoclasts are critical cells in bone metabolism and are targets for cadmium (Cd)-induced bone diseases.
- Rho GTPases are vital regulators of osteoclast differentiation and bone resorption.
- Identifying therapeutic targets for Cd-induced bone diseases is crucial.
Purpose of the Study:
- To investigate the role of Rho GTPases in osteoclast differentiation under cadmium influence.
- To elucidate signal transduction pathways affected by cadmium in osteoclasts.
- To identify potential therapeutic targets for cadmium-induced bone pathologies.
Main Methods:
- Exposure of osteoclastic precursor cells and mature osteoclasts to varying concentrations of cadmium (10 nM to 5 μM).
- Analysis of cell morphology, migration, and fusion.
- Quantitative assessment of mRNA and protein levels of Rho GTPases (Cdc42, RhoQ, Rac1, Rac2, RhoU, RhoB, RhoA) and downstream effectors (ROCK1, ROCK2, ARP2/3, p-cofilin).
- In vivo studies using bone marrow cells from cadmium-exposed mice.
Main Results:
- Low cadmium concentration (10 nM) promoted osteoclast precursor migration and upregulated Cdc42, RhoQ, ROCK1/2, while downregulating ARP2/3.
- Higher cadmium concentrations (2-5 μM) inhibited migration, reduced ROCK1/2 and ARP2/3 levels, and affected p-cofilin and various Rho GTPase mRNAs.
- Cadmium exposure in vivo increased the levels of Rho GTPases and their mRNAs in bone marrow cells.
- Cadmium significantly altered osteoclast differentiation and Rho GTPase expression.
Conclusions:
- Cadmium significantly impacts osteoclast differentiation and function through modulation of Rho GTPase signaling pathways.
- Altered expression of Rho GTPases (Cdc42, RhoQ, Rac1, Rac2, RhoU, RhoB, RhoA) and their downstream targets are key mechanisms in cadmium-induced bone toxicity.
- Rho GTPases represent potential therapeutic targets for mitigating cadmium-induced bone diseases.
Related Concept Videos
Small GTPases - Ras and Rho
Three regulatory proteins control their activity:
Calmodulin-dependent Signaling
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
Activation and Inactivation of G Proteins
Cell Polarization by Rho Proteins
Osteoclasts in Bone Remodeling
Amplifying Signals via Enzymatic Cascade

